Form D · Other

Griffith Laboratories International, Inc.

Alsip, IL · CIK 0001597696

Offering snapshot reported Nov 25, 2014 · SEC filing

Reported sold
$15M
Offering amount: $15M
Investors reported
3
Form D · investor count
Minimum accepted
$1M
Reported outside-investor minimum
First sale
Nov 14, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 25, 2014Initial$15,000,000No comparison3SEC filing
Jan 23, 2014Initial$45,000,000No comparison5SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$37.5K
Finders' fees
$0
Form D file number
021-229032

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
n/aNoneGlaucon Capital Partners, L.L.C. · CRD 103770

Source: Form D, filed Nov 25, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Drew M. Bandusky Executive
Herve De La Vauvre Director, Executive
D. Theodore Flores, Jr. Executive
William C. Frost Executive
Dean L. Griffith Director, Executive
Lois Jo Griffith Director
Brian L. Griffith Director, Executive
Dr. Ben C. Johnson Director
James S. Legg Executive
Dr. Susan L. Lind Director
Joseph R. Maslick, Jr. Director, Executive
Norman H. Mc Millan Director
Nancy E. Rossmiller Executive
A. Christian Schauer Director
Carl A. Walters Executive

Issuer details

Industry: Other (See others in industry)

Address:
One Griffith Center
Alsip, IL, 60803-3495